2Patel SC, Mody A. Cerebral hemorrhagic complications of thrombolytic therapy. Prog Cardiovasc Dis, 1999,42(3) :217-233.
3Wardlaw JM, Sandercock PA, Warlow CP, et al. Trials of thrombolysis in acute ischemic stroke: does the choice of primary outcome measure really matter? Stroke, 2000, 31(5): 1133-1135.
5Wholey MH, Wholey MH, Eles G. Cervical carotid artery stent placement. Semin Interv Cardiol, 1998, 3(2): 105-115.
6Wholey MH, Wholey M, Bergeron P, et al. Current global status of carotid artery stent placement. Cathet Cardiovasc Diagn, 1998, 44(1): 1-6.
7Waigand J, Gross CM, Uhlich F, et al. Elective stenting of carotid artery stenosis in patients with severe coronary artery disease. Eur Heart J, 1998, 19(9): 1365-1370.
8Painter JA, Mintz GS, Wong SC, et al. Serial intravascular uitra- sound studies fail to show evidence of chronic Palmaz-Schatz stent recoil. Am J Cardiol, 1995, 75(5): 398-400.
9Liu AY, Pauisen RD, Marcellus ML, et al. Long-term outcomes after carotid stent placement treatment of carotid artery dissection. Neurosurgery, 1999, 45(6): 1368-1374.
10Cohen EA, Schwartz L. Coronary artery stenting: indications and cost implications. Prog Cardiovasc Dis, 1996.39(2): 83-110,
1Markus R,Reutens DC,Kazui S,et al.Topography and temporal evolution of hypoxic viable tissue identified by ^18F-fluoromisonidazole positron emission tomography in humans after ischemic stroke.Stroke,2003,34:2646-2652.
2Takahashi W,Takagi S,Ide M,et al.Global reduction of cerebral glucose metabolism in persons with symptomatic as well as asymptomatic lacunar infarction.Keio J Med,2000,49:A98-A100.
3Saito N,Nakagawara J,Nakamura H,et al.Assessment of cerebral hemodynamics in childhood moyamoya disease using a quantitative and a semiquantitative IMP-SPECT study.Ann Nucl Med,2004,18:323-331.
